IMMUNIC, INC.

IMUX

IMMUNIC, INC.

IMUX

Insider Sentiment (TTM):

Last Purchase:2025-06-13Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:57,267,156Shares Outstanding:30,136,324Institutional Ownership Pct.:190.03%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	155	187	15	35	55	14	36	59	80	97	47	60
Other Short Term Investments	-	-	-	-	-	-	-	-	-	-	0	0
Prepaid Expense And Other Assets Current	3	2	7	4	5	5	4	4	5	5	6	6
Assets Current	158	189	23	39	60	19	39	63	85	103	53	65
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	0	0	0
Operating Lease Right Of Use Asset	1	0	1	1	1	1	1	1	1	1	1	1
Assets	159	190	24	41	61	21	41	65	86	104	54	67
Liabilities And Stockhold…
Other Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current
Accounts Payable Current	13	11	10	8	8	6	8	6	8	7	5	3
Accrued Liabilities Current	18	22	19	19	18	18	13	16	14	12	19	14
Other Liabilities Current	1	5	2	3	1	1	1	1	1	1	1	1
Liabilities Current	31	38	31	30	27	26	22	23	23	20	25	18
Liabilities Noncurrent
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	1	1
Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	1	1
Liabilities	32	39	31	30	28	26	22	24	23	21	25	19
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	800	789	599	597	595	528	526	524	522	520	436	434
Accumulated Other Comprehensive Income Loss Net Of…	3	3	3	3	3	4	4	4	4	4	4	4
Retained Earnings Accumulated Deficit	-675	-641	-609	-589	-564	-537	-511	-486	-462	-440	-411	-389
Stockholders Equity	128	151	-7	10	34	-5	18	41	64	84	29	48
Liabilities And Stockholders Equity	159	190	24	41	61	21	41	65	86	104	54	67
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	130	130
Common Stock Shares Issued	14	14	90	99	10	9	90	9	9	9	5	4
Shares Outstanding	14	14	90	99	10	9	90	9	9	9	5	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.39%	14.29%	8.03%	-	-	-	-	-	-	-	-	-
2025	-20.88%	-27.01%	-6.43%	-9.09%	4.10%	-14.86%	-6.73%	-18.23%	-12.34%	16.03%	5.49%	27.43%
2024	-2.36%	-12.60%	14.17%	12.69%	15.67%	3.73%	5.08%	-12.71%	-13.56%	1.83%	-15.78%	-33.94%
2023	-	-	-	-	-	-	19.19%	40.40%	23.23%	7.38%	18.03%	4.10%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.05	4.92	0.75	1.31	2.19	0.74	1.77	2.71	3.75	5.09	2.12	3.67
Quick Ratio	4.96	4.86	0.51	1.17	2.03	0.56	1.61	2.53	3.51	4.83	1.89	3.36
Working Capital	126.57M	150.40M	-7.75M	9.19M	32.53M	-6.62M	17.16M	39.91M	62.30M	82.47M	27.81M	47.45M
Leverage & Debt
Debt to Equity	0.25	0.25	-4.60	2.88	0.81	-4.88	1.22	0.57	0.36	0.25	0.88	0.38
Debt Ratio	0.20	0.20	1.28	0.74	0.45	1.26	0.55	0.36	0.26	0.20	0.47	0.28
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.62	-3.46	-0.62	-0.53	-7.70	-9.51	-1.00	-0.96	-9.41	-10.06	-21.12	-28.83
Free Cash Flow Per Share TTM	-2.18	-2.70	-0.55	-0.35	-5.18	-8.18	-0.85	-0.75	-7.19	-7.76	-16.06	-16.17
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	9.55%	8.19%	-3.32%	6.34%	6.85%	-1.56%	7.37%	-24.60%	-24.94%	-21.58%	-22.25%	50.98%
EPS Growth (1Y)	-65.94%	-63.62%	-37.79%	-44.46%	-18.13%	-5.49%	-95.25%	-96.68%	-67.07%	-64.81%	-44.18%	3.53%
Valuation Metrics
P/E TTM	-5.86	-3.21	-8.56	-16.60	-0.91	-1.15	-9.97	-17.24	-1.18	-1.31	-0.71	-0.51
P/B TTM	5.12	2.21	-124.59	162.89	2.72	-20.89	54.36	40.54	1.77	1.54	2.30	1.35
Market Cap	653.44M	334.51M	831.37M	1.71B	92.26M	110.47M	1.00B	1.67B	112.41M	128.44M	66.48M	65.52M
Enterprise Value	498.34M	147.88M	815.89M	1.68B	36.95M	96.16M	966.08M	1.61B	32.71M	31.12M	19.81M	5.84M
Calculated Values
Free Cash Flow TTM	-92.52M	-81.45M	-85.97M	-67.87M	-68.50M	-82.85M	-85.03M	-76.26M	-72.77M	-75.55M	-71.16M	-72.08M
Net Debt	-155.10M	-186.63M	-15.48M	-35.13M	-55.31M	-14.30M	-35.67M	-59.07M	-79.70M	-97.31M	-46.67M	-59.69M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-13Purchase

Owner: Nash, Duane

Title: Executive Chairman

Shares: 20,000

Price/Share: $0.83

Value: $16,600.00

Shares Owned: 36,032

Relationship: Director,Officer

Ownership: Direct

2025-06-05Purchase

Owner: Neermann, Joerg

Title: -

Shares: 30,000

Price/Share: $0.76

Value: $22,800.00

Shares Owned: 200,000

Relationship: Director

Ownership: Direct

2025-06-05Purchase

Owner: Tardio, Jason

Title: President and COO

Shares: 12,512

Price/Share: $0.79

Value: $9,884.48

Shares Owned: 12,512

Relationship: Officer

Ownership: Direct

2025-06-04Purchase

Owner: Vitt, Daniel

Title: CEO and Director

Shares: 15,000

Price/Share: $0.77

Value: $11,550.00

Shares Owned: 29,000

Relationship: Director,Officer

Ownership: Direct

2025-06-03Purchase

Owner: Whaley, Glenn

Title: Chief Financial Officer

Shares: 45,000

Price/Share: $0.71

Value: $31,950.00

Shares Owned: 95,510

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-13	Nash, Duane	Director,Officer	Executive Chairman	Direct	Purchase	20,000	0.83	$16,600.00	36,032	4
2025-06-05	Neermann, Joerg	Director	-	Direct	Purchase	30,000	0.76	$22,800.00	200,000	4
2025-06-05	Tardio, Jason	Officer	President and COO	Direct	Purchase	12,512	0.79	$9,884.48	12,512	4/A
2025-06-04	Vitt, Daniel	Director,Officer	CEO and Director	Direct	Purchase	15,000	0.77	$11,550.00	29,000	4/A
2025-06-03	Whaley, Glenn	Officer	Chief Financial Officer	Direct	Purchase	45,000	0.71	$31,950.00	95,510	4
2025-06-03	Rudick, Richard Alan	Director	-	Direct	Purchase	143,075	0.70	$100,152.50	230,375	4
2024-11-12	Rudick, Richard Alan	Director	-	Direct	Purchase	87,300	1.15	$100,395.00	87,300	4
2024-02-26	Vitt, Daniel	Director,Officer	President and CEO	Indirect	Purchase	14,000	1.31	$18,340.00	390,877	4
2023-05-15	Whaley, Glenn	Officer	Chief Financial Officer	Direct	Purchase	5,000	1.75	$8,750.00	25,510	4
2022-12-14	Neermann, Joerg	Director	-	Direct	Purchase	47,000	1.26	$59,220.00	100,000	4
2022-11-23	Neermann, Joerg	Director	-	Direct	Purchase	18,000	1.39	$25,020.00	18,000	4
2022-11-22	Vitt, Daniel	Director,Officer	President and CEO	Indirect	Purchase	8,000	1.35	$10,800.00	376,877	4
2022-11-07	Whaley, Glenn	Officer	Chief Financial Officer	Direct	Purchase	5,000	1.50	$7,500.00	20,510	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

190.03%

Inst. Shares: 57,267,156

Shares Outstanding: 30,136,324

2025-12-31

32.59%

Inst. Shares: 50,742,504

Shares Outstanding: 155,688,030

2025-09-30

21.84%

Inst. Shares: 42,354,438

Shares Outstanding: 193,897,764

2025-06-30

37.95%

Inst. Shares: 50,158,985

Shares Outstanding: 132,175,202

2025-03-31

Inst. Shares: 40,097,059

Shares Outstanding: 10,134,443

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	57,267,156	30,136,324	190.03%
2025-12-31	50,742,504	155,688,030	32.59%
2025-09-30	42,354,438	193,897,764	21.84%
2025-06-30	50,158,985	132,175,202	37.95%
2025-03-31	40,097,059	10,134,443	-
2024-12-31	50,742,291	100,174,766	50.65%
2024-09-30	55,794,721	101,272,580	55.09%
2024-06-30	55,671,752	101,272,580	54.97%
2024-03-31	56,321,657	97,299,955	57.88%
2023-12-31	13,859,086	44,320,050	31.27%
2023-09-30	17,038,296	44,574,377	38.22%
2023-06-30	19,326,528	44,432,955	43.50%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

IMMUNIC, INC. (IMUX) — SEC Financial Statements & Analysis

IMMUNIC, INC. (IMUX) is a pharmaceutical preparations company, incorporated in DE. IMMUNIC, INC. trades on Nasdaq as: IMUX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IMMUNIC, INC. reported a Debt-to-Equity ratio of 0.25x, a Price-to-Book (P/B) ratio of 5.12x (TTM), at a market cap of $653.44M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.25x
P/B TTM: 5.12x
Market Cap: $653.44M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IMMUNIC, INC. in?

IMMUNIC, INC. (IMUX) operates in the Pharmaceutical Preparations industry.

What is IMUX's market cap?

IMMUNIC, INC. (IMUX) has a market capitalization of $653.44M as of 2026-06-30.

What exchange does IMUX trade on?

IMMUNIC, INC. (IMUX) trades on the Nasdaq.

Where is IMMUNIC, INC. incorporated?

IMMUNIC, INC. is incorporated in DE.

IMMUNIC, INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

IMMUNIC, INC. (IMUX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

IMMUNIC, INC. (IMUX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.